Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Merck
Harvard Business School
Moodys
Colorcon

Last Updated: January 25, 2022

DrugPatentWatch Database Preview

Drug Sales Trends for ALPRAZOLAM


Email this page to a colleague

« Back to Dashboard

Payment Methods and Pharmacy Types for ALPRAZOLAM (2019)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $6,316,473
INSIDE ANOTHER STORE $56,006,405
[disabled in preview] $151,564,356
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 860,493
INSIDE ANOTHER STORE 4,721,177
[disabled in preview] 11,849,450
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $17,489,371
MEDICARE $53,862,361
[disabled in preview] $142,859,035
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for ALPRAZOLAM
Drug Units Sold Trends for ALPRAZOLAM

Annual Sales Revenues and Units Sold for ALPRAZOLAM

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
ALPRAZOLAM ⤷  Try it Free ⤷  Try it Free 2019
ALPRAZOLAM ⤷  Try it Free ⤷  Try it Free 2018
ALPRAZOLAM ⤷  Try it Free ⤷  Try it Free 2017
ALPRAZOLAM ⤷  Try it Free ⤷  Try it Free 2016
ALPRAZOLAM ⤷  Try it Free ⤷  Try it Free 2015
ALPRAZOLAM ⤷  Try it Free ⤷  Try it Free 2014
ALPRAZOLAM ⤷  Try it Free ⤷  Try it Free 2013
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Express Scripts
Mallinckrodt
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.